Thomas Staab, II

Portrait
Thomas Staab, II, Chief Financial Officer

Thomas Staab has served as our chief financial officer since May 2020. Before joining us, Mr. Staab served as a senior vice president, chief financial officer and treasurer at BioCryst Pharmaceuticals, Inc., a biopharmaceutical company, from July 2011 to February 2020. Prior to BioCryst, Mr. Staab served as executive vice president, chief financial officer and treasurer of Inspire Pharmaceuticals from May 2003 through its acquisition by Merck & Co., Inc. in May 2011, and acting chief financial officer and treasurer at Triangle Pharmaceuticals, Inc. through its acquisition by Gilead Sciences, Inc. in 2003. Before joining industry, Mr. Staab spent eight years working for PricewaterhouseCoopers LLP providing audit and business advisory services to national and multi-national corporations in various industries. He is a Certified Public Accountant and received a BS in Business Administration and a Master of Accounting from the University of North Carolina at Chapel Hill.